Axiom Therapeutics
Entrepreneur First '24London, GB · Founded 2024 · 4 known investors
Find your way into Axiom Therapeutics
628 people in our graph share verified history with the Axiom Therapeutics team — schools, employers, funds. One of them is your warm intro.
Axiom Therapeutics runs a drug discovery platform for covalent inhibitors, applying machine learning to speed up physics-based simulations. The work is aimed at oncology research teams pursuing targets that have been difficult to drug.
Also known as Axiom
Founders & leadership
Axiom Therapeutics was founded in 2024 by Ryan Geiser and Chris Haggard.
Investors · 4
Company profile
researched Aug 2026Axiom Therapeutics is a drug discovery company founded in 2024 and headquartered in London, United Kingdom. It operates a platform for designing covalent inhibitors, using machine learning to accelerate physics-based molecular simulations with the aim of producing more precise and potent therapies, including for targets regarded as difficult to drug.
The company's stated focus is on oncology research and on diseases that currently lack effective treatments. It is listed in the portfolio of Entrepreneurs First, the London-based talent investor whose portfolio directory catalogues companies by location, industry, founding year and stage.
Latest developments
No dated developments are documented in the available sources beyond the company's inclusion in the Entrepreneurs First portfolio listing.
▸Full profile — market position, technology, go-to-market, geography, risks & controversies
Market position
An early-stage company within the Entrepreneurs First portfolio, which also includes other European biotechnology and pharmaceuticals companies such as Spore.Bio, Ochre Bio, Genomines, Phagos and Faircraft; the available sources do not describe Axiom Therapeutics' competitive standing in more detail.
Technology
The company's approach combines machine learning with physics-based simulation to shorten the computational time required for modelling covalent inhibitor binding, applied to the design of covalent small-molecule drugs.
Go-to-market
Oncology-focused drug discovery and research teams, particularly those pursuing targets considered hard to drug.
Geography
London, United Kingdom.
Risks & controversies
No risks or controversies specific to the company are reported in the available sources. Note that public material exists on unrelated entities with similar names, including Axiom Health (acquired by Sorcero in July 2025) and Spotlight Therapeutics; neither is connected to Axiom Therapeutics.
Compiled by commissioned research from 3 cited public sources — announcements, filings, and press listed under research sources below.
Companies House · registry record
View on Companies House ↗- Registered name
- AXIOM THERAPEUTICS LTD
- Company number
- 15896164
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 14 Aug 2024
- Registered office
- 9th Floor 107 Cheapside, London, EC2V 6DN
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Aug 2025 · next due 31 May 2027
- Confirmation statement
- last made up to 13 Aug 2026 · next due 27 Aug 2027
Current officers · 3
- Ohs Secretaries Limited — corporate secretary, appointed 14 Aug 2024
- Ryan John Geiser — director, appointed 14 Aug 2024
- Christopher Patrick Hamilton Haggard — director, appointed 14 Aug 2024
Source: Companies House public register · retrieved 23 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
▸Research sources · 3
primary sources listed
- Axiom Therapeutics | Portfolio | Entrepreneurs Firstjoinef.com · web
3 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Axiom Therapeutics do?
- London-based drug discovery startup applying machine learning to physics simulations for covalent inhibitor design in oncology.
- Who founded Axiom Therapeutics?
- Axiom Therapeutics was founded by Ryan Geiser, Chris Haggard in 2024.
- Who are Axiom Therapeutics's investors?
- Axiom Therapeutics's investors include Entrepreneur First, Lunar Ventures, Samos Investments, Transpose Platform Management.
- Where is Axiom Therapeutics headquartered?
- Axiom Therapeutics is headquartered in London, GB.